Market Overview

ThermoGenesis Announces Approval of AXP by India Ministry of Health


ThermoGenesis Corp. (NASDAQ: KOOL) said today that India's Ministry of Health has approved the AutoXpress® System, enabling the Company to initiate commercial sales of the product in India. The AXP is used for the processing of stem cells from cord blood.

Posted-In: News FDA


Related Articles (KOOL)

View Comments and Join the Discussion!